SCHEMBL25015308

SCHEMBL25015308

CC(=O)OCCSc1ccc(C#C[Si](C)(C)C)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 3/20 0.35
GABRA5 P31644 3/20 0.35
GABRG2 P18507 2/20 0.35
GABRB3 P28472 2/20 0.35
GABRA3 P34903 2/20 0.35
GABRA2 P47869 2/20 0.35
GABRA4 P48169 2/20 0.35
GABRA6 Q16445 1/20 0.35
MTNR1A P48039 2/20 0.35
MTNR1B P49286 2/20 0.35
PTGS2 P35354 1/20 0.34
ADK P55263 2/20 0.32
RAB9A P51151 1/20 0.32
ALDH1A1 P00352 4/20 0.32
MAPT P10636 3/20 0.32
RECQL P46063 2/20 0.32
CYP3A4 P08684 2/20 0.32
CYP2D6 P10635 2/20 0.32
CYP2C19 P33261 2/20 0.32
MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25015145 0.82 PPARD (0.38) GABRA1GABRA5GABRG2GABRB3GABRA3
SCHEMBL25015312 0.80 MTNR1A (0.35) MTNR1AMTNR1BPTGS2RAB9AALDH1A1
SCHEMBL25015299 0.80 MAOB (0.43) MTNR1AMTNR1BRAB9AALDH1A1MAPT
SCHEMBL25015310 0.79 MTNR1A (0.38) MTNR1AMTNR1BPTGS2RAB9AALDH1A1
SCHEMBL14721106 0.76 LMNA (0.45) GABRA1GABRA5GABRG2GABRB3GABRA3
SCHEMBL43368 0.76 ALDH1A1 (0.51) GABRA1GABRA5GABRG2GABRB3GABRA3
SCHEMBL25015144 0.76 FFAR1 (0.35) MTNR1AMTNR1BPTGS2ALDH1A1MAPT
SCHEMBL27858437 0.75 HSP90AA1 (0.45) MTNR1AMTNR1BPTGS2RAB9AALDH1A1
SCHEMBL1710082 0.75 ALDH1A1 (0.49) RAB9AALDH1A1MAPTCYP3A4CYP2C19
SCHEMBL25015315 0.74 DUT (0.32) ADK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230042009-A1 COMPOUND, COMPOSITION, CURED SUBSTANCE, OPTICALLY ANISOTROPIC BODY, OPTICAL ELEMENT, AND LIGHT GUIDE ELEMENT FUJIFILM CORPORATION (JP) 2023-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230042009-A1 COMPOUND, COMPOSITION, CURED SUBSTANCE, OPTICALLY ANISOTROPIC BODY, OPTICAL ELEMENT, AND LIGHT GUIDE ELEMENT SP1, C5, ZYX GABRA1 4051/4885GABRA5 4564/4885GABRG2 3538/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.